LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 28, 2024 | (Q2)Mar 29, 2024 | (Q1)Dec 29, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -32.02%549.03M | -18.37%199.08M | -34.75%104.63M | -57.36%87.22M | -20.49%158.11M | 2.64%807.63M | -41.24%243.89M | -23.87%160.35M | 219.77%204.55M | 104.60%198.85M |
Net income from continuing operations | -31.46%472.87M | -48.11%73.12M | -38.69%123.42M | -20.80%137.95M | -20.24%138.38M | -24.47%689.9M | -36.18%140.93M | -20.85%201.29M | -25.39%174.19M | -15.30%173.49M |
Operating gains losses | ---- | ---- | -193.75%-150K | ---- | ---- | ---- | ---- | --160K | ---- | ---- |
Depreciation and amortization | 11.31%151.21M | 14.11%41.61M | 3.02%37.69M | 10.40%36.76M | 19.17%35.16M | 38.15%135.85M | 30.24%36.46M | 53.68%36.58M | 42.54%33.3M | 27.34%29.51M |
Deferred tax | -73.80%3.37M | -68.40%4.43M | 119.16%1.55M | -126.00%-945K | -150.93%-1.67M | 321.09%12.86M | -10.65%14.03M | 3.56%-8.08M | 150.69%3.64M | 157.26%3.28M |
Other non cash items | -88.84%1.08M | -212.23%-3.49M | -110.65%-1.18M | 161.45%3.67M | 47.09%2.07M | 37.58%9.63M | 149.59%3.11M | 91.29%11.09M | -274.39%-5.97M | -65.19%1.41M |
Change In working capital | -56.62%-104.89M | 73.73%71.66M | 29.39%-61.18M | -1,168.74%-94.78M | -46.07%-20.6M | 74.48%-66.97M | -71.26%41.25M | -24.60%-86.65M | 96.34%-7.47M | 89.36%-14.1M |
-Change in receivables | 340.21%72.73M | 365.75%15.01M | 118.74%6.19M | 128.16%7.7M | 63.32%43.84M | -270.59%-30.28M | -98.44%3.22M | 65.00%-33M | 66.94%-27.34M | 318.20%26.84M |
-Change in inventory | 24.75%-31.92M | 269.24%48.75M | 87.31%-7.71M | -310.85%-74.98M | -82.58%2.02M | 73.65%-42.42M | -248.13%-28.81M | -143.78%-60.74M | 167.48%35.56M | 115.40%11.57M |
-Change in prepaid assets | -66.88%-18.61M | -67.40%-6.97M | -229.42%-2.56M | 102.95%60K | -31.89%-9.14M | 48.65%-11.15M | 7.05%-4.17M | 171.92%1.98M | 29.94%-2.03M | 40.21%-6.93M |
-Change in payables and accrued expense | -795.66%-132.41M | -238.59%-20.18M | -180.78%-55.35M | -94.81%1.08M | 31.73%-57.96M | 120.13%19.03M | 111.82%14.56M | 45.74%68.52M | 14.85%20.85M | -132.55%-84.9M |
-Change in other working capital | 346.59%5.32M | -37.89%35.05M | 97.24%-1.75M | 17.00%-28.64M | -98.35%650K | 26.73%-2.16M | -22.11%56.44M | -1,275.58%-63.41M | 58.78%-34.5M | 1,250.70%39.32M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -32.02%549.03M | -18.37%199.08M | -34.75%104.63M | -57.36%87.22M | -20.49%158.11M | 2.64%807.63M | -41.24%243.89M | -23.87%160.35M | 219.77%204.55M | 104.60%198.85M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 48.92%-154.34M | 54.64%-43.66M | 36.35%-31.71M | 26.28%-28.67M | 57.07%-50.3M | 31.76%-302.15M | 9.28%-96.26M | 81.94%-49.82M | -146.51%-38.89M | -160.28%-117.19M |
Capital expenditure reported | 31.54%-149.86M | 53.54%-44.76M | 36.70%-31.55M | 22.47%-29.22M | -26.64%-44.33M | -61.21%-218.89M | -79.14%-96.35M | 12.01%-49.85M | -135.75%-37.68M | -274.08%-35.01M |
Net PPE purchase and sale | 1,169.11%1.56M | 1,100.00%1.1M | -403.33%-91K | ---- | ---- | -84.21%123K | -23.97%92K | 87.50%30K | ---- | ---- |
Net business purchase and sale | 92.76%-6.04M | --0 | ---63K | --0 | 92.73%-5.97M | 72.91%-83.39M | --0 | --0 | ---1.2M | -127.66%-82.18M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 48.92%-154.34M | 54.64%-43.66M | 36.35%-31.71M | 26.28%-28.67M | 57.07%-50.3M | 31.76%-302.15M | 9.28%-96.26M | 81.94%-49.82M | -146.51%-38.89M | -160.28%-117.19M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 14.11%-435.28M | -47.23%-110.69M | 6.97%-137.07M | 41.91%-69.38M | 28.32%-118.15M | 3.32%-506.78M | 26.99%-75.18M | -8.60%-147.34M | 23.70%-119.43M | -27.73%-164.83M |
Net issuance payments of debt | -48.26%-1.96M | -68.18%-555K | -53.94%-508K | 29.24%-467K | ---427K | ---1.32M | ---330K | ---330K | ---660K | --0 |
Net common stock issuance | 21.09%-398.86M | -32.16%-98.92M | 14.95%-125.03M | 51.85%-57.19M | 28.58%-117.73M | 3.58%-505.46M | 27.31%-74.85M | -8.36%-147.01M | 24.12%-118.77M | -27.73%-164.83M |
Cash dividends paid | ---34.46M | ---11.21M | ---11.53M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 14.11%-435.28M | -47.23%-110.69M | 6.97%-137.07M | 41.91%-69.38M | 28.32%-118.15M | 3.32%-506.78M | 26.99%-75.18M | -8.60%-147.34M | 23.70%-119.43M | -27.73%-164.83M |
Net cash flow | ||||||||||
Beginning cash position | -0.16%388.11M | -4.45%303.66M | 3.87%368.05M | 23.75%380.92M | -0.16%388.11M | -32.54%388.75M | 70.27%317.81M | -9.24%354.34M | -38.31%307.83M | -32.54%388.75M |
Current changes in cash | -3,026.73%-40.59M | -38.26%44.73M | -74.26%-64.14M | -123.42%-10.83M | 87.55%-10.35M | 99.28%-1.3M | -64.83%72.45M | 81.68%-36.81M | 142.67%46.23M | -8.18%-83.17M |
Effect of exchange rate changes | 483.36%3.86M | 239.96%3M | -193.75%-255K | -810.76%-2.05M | 40.88%3.16M | 108.97%661K | 44.85%-2.14M | 109.70%272K | 226.32%288K | 598.44%2.24M |
End cash Position | -9.46%351.39M | -9.46%351.39M | -4.45%303.66M | 3.87%368.05M | 23.75%380.92M | -0.16%388.11M | -0.16%388.11M | 70.27%317.81M | -9.24%354.34M | -38.31%307.83M |
Free cash flow | -32.20%399.17M | 4.60%154.31M | -33.87%73.08M | -65.24%58M | -30.56%113.78M | -9.57%588.75M | -59.16%147.53M | -28.23%110.51M | 247.76%166.86M | 86.54%163.85M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |